Literature DB >> 15542858

Identification of the structural and functional domains of the large serine recombinase TnpX from Clostridium perfringens.

Isabelle S Lucet1, Fleur E Tynan, Vicki Adams, Jamie Rossjohn, Dena Lyras, Julian I Rood.   

Abstract

Members of the large serine resolvase family of site-specific recombinases are responsible for the movement of several mobile genetic elements; however, little is known regarding the structure or function of these proteins. TnpX is a serine recombinase that is responsible for the movement of the chloramphenicol resistance elements of the Tn4451/3 family. We have shown that TnpX binds differentially to its transposon and target sites, suggesting that resolvase-like excision and insertion were two distinct processes. To analyze the structural and functional domains of TnpX and, more specifically, to define the domains involved in protein-DNA and protein-protein interactions, we conducted limited proteolysis studies on the wild-type dimeric TnpX(1-707) protein and its functional truncation mutant, TnpX(1-597). The results showed that TnpX was organized into three major domains: domain I (amino acids (aa) 1-170), which included the resolvase catalytic domain; domain II (aa 170-266); and domain III (aa 267-707), which contained the dimerization region and two separate regions involved in binding to the DNA target. A small polypeptide (aa 533-587) was shown to bind specifically to the TnpX binding sites providing further evidence that it was the primary DNA binding region. In addition, a previously unidentified DNA binding site was shown to be located between residues 583 and 707. Finally, the DNA binding and multerimization but not the catalytic functions of TnpX could be reconstituted by recombining separate polypeptides that contain the N- and C-terminal regions of the protein. These data provide evidence that TnpX has separate catalytic, DNA binding, and multimerization domains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542858     DOI: 10.1074/jbc.M409702200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  New transposon Tn6133 in methicillin-resistant Staphylococcus aureus ST398 contains vga(E), a novel streptogramin A, pleuromutilin, and lincosamide resistance gene.

Authors:  Sybille Schwendener; Vincent Perreten
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

2.  Functional identification of conjugation and replication regions of the tetracycline resistance plasmid pCW3 from Clostridium perfringens.

Authors:  Trudi L Bannam; Wee Lin Teng; Dieter Bulach; Dena Lyras; Julian I Rood
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

3.  Multiple genetic elements carry the tetracycline resistance gene tet(W) in the animal pathogen Arcanobacterium pyogenes.

Authors:  Stephen J Billington; B Helen Jost
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

4.  Mutational analysis of highly conserved residues in the phage phiC31 integrase reveals key amino acids necessary for the DNA recombination.

Authors:  Shaohui Liu; Jinfang Ma; Wei Wang; Maoxiang Zhang; Qingting Xin; Siman Peng; Rongxiu Li; Huanzhang Zhu
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

5.  The site-specific integration reaction of Listeria phage A118 integrase, a serine recombinase.

Authors:  Sridhar Mandali; Gautam Dhar; Nuraly K Avliyakulov; Michael J Haykinson; Reid C Johnson
Journal:  Mob DNA       Date:  2013-01-03

6.  Sequences in attB that affect the ability of phiC31 integrase to synapse and to activate DNA cleavage.

Authors:  Milind Gupta; Rob Till; Margaret C M Smith
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

7.  Control of ϕC31 integrase-mediated site-specific recombination by protein trans-splicing.

Authors:  Femi J Olorunniji; Makeba Lawson-Williams; Arlene L McPherson; Jane E Paget; W Marshall Stark; Susan J Rosser
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.